AU2001277786A1 - Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase - Google Patents

Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase

Info

Publication number
AU2001277786A1
AU2001277786A1 AU2001277786A AU7778601A AU2001277786A1 AU 2001277786 A1 AU2001277786 A1 AU 2001277786A1 AU 2001277786 A AU2001277786 A AU 2001277786A AU 7778601 A AU7778601 A AU 7778601A AU 2001277786 A1 AU2001277786 A1 AU 2001277786A1
Authority
AU
Australia
Prior art keywords
composition containing
matrix metalloproteinase
ginkgo biloba
inhibit angiogenesis
containing ginkgo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277786A
Inventor
Min-Young Kim
Chang-Hee Moon
Byung-Young Park
Eun-Kyu Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiolab Inc
Original Assignee
Angiolab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2000-0045265A external-priority patent/KR100417172B1/en
Priority claimed from KR10-2001-0011850A external-priority patent/KR100477507B1/en
Application filed by Angiolab Inc filed Critical Angiolab Inc
Publication of AU2001277786A1 publication Critical patent/AU2001277786A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001277786A 2000-08-04 2001-08-03 Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase Abandoned AU2001277786A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR0045265 2000-08-04
KR10-2000-0045265A KR100417172B1 (en) 2000-08-04 2000-08-04 Angiogenesis inhibitor containing ginkgo biloba extract
KR10-2001-0011850A KR100477507B1 (en) 2001-03-07 2001-03-07 Pharmaceutical composition containing ginkgo biloba extract for the use of matrix metalloproteinase inhibitor
KR0111850 2001-03-07
PCT/KR2001/001325 WO2002011745A1 (en) 2000-08-04 2001-08-03 Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase

Publications (1)

Publication Number Publication Date
AU2001277786A1 true AU2001277786A1 (en) 2002-02-18

Family

ID=26638280

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277786A Abandoned AU2001277786A1 (en) 2000-08-04 2001-08-03 Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase

Country Status (2)

Country Link
AU (1) AU2001277786A1 (en)
WO (1) WO2002011745A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2536604A1 (en) * 2002-08-30 2004-03-11 Biopharmacopae Design International Inc. Plant extracts for treatment of angiogenesis and metastasis
CA2498141C (en) * 2002-09-09 2012-07-10 Nestec S.A. Orally administrable composition for improving skin quality
FR2857266B1 (en) * 2003-07-07 2007-09-21 Jean Noel Thorel COMPOSITION FOR DERMATOLOGICAL AND / OR COSMETIC USE, COMPRISING AS ACTIVE INGREDIENT AT LEAST ONE LIPOPHILIC ANTIOXIDANT
KR20050081597A (en) * 2004-02-16 2005-08-19 한국 메디텍 제약 주식회사 Drug for osteoporosis having inhibition effect on cancer comprising ginkgo biloba extracts as the active ingredient
JP5294536B2 (en) * 2005-03-31 2013-09-18 小林製薬株式会社 Gingival epithelial cell spreading inhibitor
CN104857040A (en) * 2015-06-03 2015-08-26 广西梧州制药（集团）股份有限公司 New purpose of embelia parviflora wall for preparing medicines for treating liver fibrosis
CN104940257B (en) * 2015-06-03 2018-12-18 广西梧州制药（集团）股份有限公司 Purposes of the smallflower embelia root and stem in terms of preparation treatment and/or prevention cell aberration drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634380B1 (en) * 1988-07-19 1990-10-12 Beljanski Mirko BIOLOGICAL REGULATOR, ACTIVE IN VARIOUS PATHOLOGIES
CA2378052C (en) * 1999-08-12 2010-03-23 Katy Drieu Use of ginkgo extract

Also Published As

Publication number Publication date
WO2002011745A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
HUP0301452A3 (en) Pharmaceutical composition containing photochemotherapeutic agent and mucoadhesive agent and its use
GB2352177B (en) Composition from ginkgo biloba leaves preparation and uses
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUP0400691A3 (en) Pyrimidineamines as angiogenesis modulators and pharmaceutical compositions containing them
HUP0302881A3 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
SG94799A1 (en) Chemically amplified positive resist composition
HUP0303621A3 (en) Pharmaceutical compositions containing combinations comprising an antidiarrheal agent and epothilone or an epothilone
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
HUP0300798A3 (en) Substituted-triazolopyrimidines and their use as anticancer agents and pharmaceutical compositions containing them
IL206621A0 (en) Caspase inhibitors and pharmaceutical compositions containing the same
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
SG99336A1 (en) Chemically amplified positive resist composition
PL354315A1 (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
HUP0302455A3 (en) Combination pharmaceutical compositions containing amplodipine and benazepril and their use
SG87205A1 (en) Chemically amplified positive resist composition
IL156577A0 (en) Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
SG94738A1 (en) Chemically amplified positive resist composition
IL137363A0 (en) Pharmaceutical compositions containing mupirocin
HUP0200747A2 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
AU2001277786A1 (en) Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase
GB2368014B (en) Pharmaceutical composition containing citalopram
IL141654A0 (en) Pyranose derivatives and pharmaceutical compositions containing the same
TWI315308B (en) Compounds with antimicrobial activity and pharmaceutical compositions used as antimicrobial agent
ZA200006020B (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.